InspireMD
NSPR
30 hedge funds and large institutions have $33.4M invested in InspireMD in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
7% more funds holding
Funds holding: 28 → 30 (+2)
1% more capital invested
Capital invested by funds: $33.2M → $33.4M (+$192K)
0.5% more ownership
Funds ownership: 48.24% → 48.74% (+0.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$2.02M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$195K |
| 3 |
Morgan Stanley
New York
|
+$93.6K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$65.8K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$49K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.44M |
| 2 |
Millennium Management
New York
|
-$185K |
| 3 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$49.1K |
| 4 |
BWP
Baldwin Wealth Partners
Marion,
Massachusetts
|
-$7.64K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.33K |
NSPR Hedge Fund Activity: Q4 2024 in Review
30 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q4 2024, worth a combined $33.4M — up 0.58% from $33.2M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NSPR positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Parkman Healthcare Partners, adding an estimated $2.02M. The largest seller was Nantahala Capital Management, cutting an estimated $1.44M.
- 30 institutional investors held InspireMD (NSPR) as of Q4 2024, up from 28 in Q3 2024.
- Funds reported $33.4M of InspireMD stock for Q4 2024, up 0.58% quarter-over-quarter.
- 4 funds opened new InspireMD positions in Q4 2024 and 2 closed out, a net change of +2 holders.
- The largest InspireMD buyer in Q4 2024 was Parkman Healthcare Partners, an estimated $2.02M added.
- The largest InspireMD seller in Q4 2024 was Nantahala Capital Management, an estimated $1.44M sold.
Based on aggregated 13F filings for Q4 2024.